MiR-31 regulates interleukin 2 and kinase suppressor of ras 2 during T cell activation

Genes and Immunity

Volumn 14, Issue 2, 2013, Pages 127-131

  Xue, F ^a   Li, H ^b,c   Zhang, J ^a   Lu, J ^a   Xia, Y ^a   Xia, Q ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Shanghai Institute of Immunology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; MICRORNA 31; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR NFAT;

3' UNTRANSLATED REGION; BIOINFORMATICS; CONTROLLED STUDY; GENE; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KINASE SUPPRESSOR OF RAS 2 GENE; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; REPORTER GENE; SHORT SURVEY; T LYMPHOCYTE ACTIVATION; UPREGULATION; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-2; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MICRORNAS; NFATC TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; UP-REGULATION;

EID: 84874760462     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2012.58     Document Type: Short Survey

References (21)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
2. Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ. Processing of primary microRNAs by the Microprocessor complex. Nature 2004; 432: 231-235.
3. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: micro- RNAs can up-regulate translation. Science 2007; 318: 1931-1934.
4. Pauley KM, Chan EK. MicroRNAs and their emerging roles in immunology. Ann NY Acad Sci 2008; 1143: 226-239.
5. Cobb BS, Nesterova TB, Thompson E, Hertweck A, O'Connor E, Godwin J et al. T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J Exp Med 2005; 201: 1367-1373.
6. Muljo SA, Ansel KM, Kanellopoulou C, Livingston DM, Rao A, Rajewsky K. Aberrant T cell differentiation in the absence of Dicer. J Exp Med 2005; 202: 261-269.
7. Lu LF, Boldin MP, Chaudhry A, Lin LL, Taganov KD, Hanada T et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 142: 914-929.
8. Wang S, Tang Y, Cui H, Zhao X, Luo X, Pan W et al. Let-7/miR-98 regulate Fas and Fas-mediated apoptosis. Genes Immun 12: 149-154.
9. Li QJ, Chau J, Ebert PJ, Sylvester G, Min H, Liu G et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007; 129: 147-161.
10. Wu H, Neilson JR, Kumar P, Manocha M, Shankar P, Sharp PA et al. miRNA profiling of naive, effector and memory CD8 T cells. PloS one 2007; 2: e1020.
11. Lu TX, Hartner J, Lim EJ, Fabry V, Mingler MK, Cole ET et al. MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J Immunol 2011; 187: 3362-3373.
12. Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 2009; 60: 1065-1075.
13. Tenbrock K, Tsokos GC. Transcriptional regulation of interleukin 2 in SLE T cells. Int Rev Immunol 2004; 23: 333-345.
14. Rouas R, Fayyad-Kazan H, El Zein N, Lewalle P, Rothe F, Simion A et al. Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur J Immunol 2009; 39: 1608-1618.
15. Valastyan S, Chang A, Benaich N, Reinhardt F, Weinberg RA. Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis. Cancer Res 2010; 70: 5147-5154.
16. Chen C, Rowell EA, Thomas RM, Hancock WW, Wells AD. Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation. J Biol Chem 2006; 281: 36828-36834.
17. Channavajhala PL, Wu L, Cuozzo JW, Hall JP, Liu W, Lin LL et al. Identification of a novel human kinase supporter of Ras (hKSR-2) that functions as a negative regulator of Cot (Tpl2) signaling. J Biol Chem 2003; 278: 47089-47097.
18. Gomez-Casero E, San-Antonio B, Iniguez MA, Fresno M. Cot/Tpl2 and PKCzeta cooperate in the regulation of the transcriptional activity of NFATc2 through the phosphorylation of its amino-terminal domain. Cell Signal 2007; 19: 1652-1661.
19. Ballester A, Velasco A, Tobena R, Alemany S. Cot kinase activates tumor necrosis factor-alpha gene expression in a cyclosporin A-resistant manner. J Biol Chem 1998; 273: 14099-14106.
20. Choi HS, Kang BS, Shim JH, Cho YY, Choi BY, Bode AM et al. Cot, a novel kinase of histone H3, induces cellular transformation through up-regulation of c-fos transcriptional activity. Faseb J 2008; 22: 113-126.
21. Gringhuis SI, de Leij LF, Verschuren EW, Borger P, Vellenga E. Interleukin-7 upregulates the interleukin-2-gene expression in activated human T lymphocytes at the transcriptional level by enhancing the DNA binding activities of both nuclear factor of activated T cells and activator protein-1. Blood 1997; 90: 2690-2700.